ArticleBiomacromolecules2026
Evaluation and Formulation of Hybridized Biobased Precursors as Anticorrosive Surface Coatings.
Article in Biomacromolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study focuses on the synthesis of an oligomeric diepoxy resin (EVAC) derived from two diverse biomass sources, cashew nutshell liquid and lignin, and its evaluation as a major component in an anticorrosion surface coating. EVAC structural verifications were performed via spectroscopic and chromatographic methods. EVAC was mixed with diglycidyl ether of bisphenol A (EPON-828) at varying ratios and cured with 5,5'-methylene difurfurylamine (DFDA) and diethylmethylbenzenediamine (Epikure W). Thermally cured blends containing DFDA demonstrated improved moduli and char yields relative to those containing Epikure W. Although the replacement of EVAC with EPON-828 resulted in a reduction in the glass transition temperature and the strength, desired hydrophobicity, flexibility, and adhesion for coatings applications were imparted. Additionally, biobased DFDA demonstrated improved coatings and corrosion performance relative to Epikure W without significantly affecting network performance. Markedly, EVAC/DFDA-based formulations demonstrated high gloss, substrate compatibility, adhesion (5B), impact resistance (>160 lb.-ft), and durability characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.